Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NASDAQ:NSTG

NanoString Technologies (NSTG) Stock Price, News & Analysis

NanoString Technologies logo

About NanoString Technologies Stock (NASDAQ:NSTG)

Key Stats

Today's Range
N/A
50-Day Range
$0.05
$0.80
52-Week Range
N/A
Volume
23.06 million shs
Average Volume
34.54 million shs
Market Capitalization
$5.07 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
Hold

Company Overview

NanoString Technologies, Inc. develops, manufactures, and sells technology for scientific and clinical information in the fields of genomics and proteomics in the Americas, Europe, the Middle East, and the Asia Pacific. The company offers nCounter Analysis System, an automated, multi-application, digital detection, and counting system. It provides nCounter Pro and FLEX systems that include Prep Station, an automated liquid handling component that processes and prepares samples for data collection; and nCounter Digital Analyzer, which collects data from samples by taking images of the immobilized fluorescent reporters in the sample cartridge and processing the data into output files. The company also offers nCounter SPRINT Profiler, an instrument that provides liquid handling steps and the digital analysis through use of a microfluidic cartridge; and nSolver Analysis Software, a data analysis program that enables researchers to check, normalize, and analyze their data. In addition, it provides custom CodeSets; panels with oncology, immunology and infectious disease, and neuroscience applications. Further, the company offers Master Kits, cartridges, ancillary reagents, tips and reagent plates to setup and process samples in instruments; and Prosigna in vitro diagnostic kits. The company is also developing GeoMx DSP system to enable the field of spatial biology. It has collaboration with Lam Research Corporation for the development of NGS sequencing platform and related assays; and Parker Institute for Cancer Immunotherapy to develop CAR-T regimens that enhances patient outcomes for various types of cancer, as well as collaboration with Stanford Medicine, Acrobat Genomics, and Illumina Accelerator to discover new drug targets for gene editing-based therapeutics. NanoString Technologies, Inc. was incorporated in 2003 and is headquartered in Seattle, Washington. On February 4, 2024, NanoString Technologies, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.

Receive NSTG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for NanoString Technologies and its competitors with MarketBeat's FREE daily newsletter.

NSTG Stock News Headlines

War on Elon Escalates…
A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.
See More Headlines

NSTG Stock Analysis - Frequently Asked Questions

NanoString Technologies, Inc. (NASDAQ:NSTG) posted its quarterly earnings data on Thursday, August, 3rd. The biotechnology company reported ($0.92) earnings per share for the quarter, missing the consensus estimate of ($0.70) by $0.22. The firm's quarterly revenue was up 37.1% on a year-over-year basis.

Based on aggregate information from My MarketBeat watchlists, some other companies that NanoString Technologies investors own include Xtrackers California Municipal Bond ETF (CA), Tesla (TSLA), BlackRock (BLK), NVIDIA (NVDA), Advanced Micro Devices (AMD), Chipotle Mexican Grill (CMG) and Meta Platforms (META).

Company Calendar

Last Earnings
8/03/2023
Today
10/31/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Medical Instruments & Supplies
Sub-Industry
N/A
Current Symbol
NASDAQ:NSTG
Employees
550
Year Founded
N/A

Profitability

Net Income
$-159,540,000.00
Net Margins
-102.44%
Pretax Margin
-102.30%

Debt

Sales & Book Value

Annual Sales
$127.26 million
Book Value
$0.98 per share

Miscellaneous

Free Float
46,626,000
Market Cap
$5.07 million
Optionable
Optionable
Beta
1.24

Social Links

Unlock the Potential in Options Trading Cover

Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Keep reading to learn how options trading can help you use the market’s volatility to your advantage.

Get This Free Report

This page (NASDAQ:NSTG) was last updated on 10/31/2024 by MarketBeat.com Staff
From Our Partners